- Jason Edward Ochs
- December 12, 2018
So implies Monsanto in the ongoing In RE Roundup litigation venued before Judge Chhabria in San Francisco, as well as a state-court consolidated filings in St. Louis, Missouri. To date, only one case has been tried and the case resulted…
- Jason Edward Ochs
- November 17, 2018
On a September afternoon in 2016, Benjamin and Kristi Reavis of Dallas, Texas were traveling south on North Central Expressway with their 3-year-old son and 5-year-old daughter in the sedan’s back seat. While stopped…
- Jason Edward Ochs
- September 14, 2018
While the opioid crisis has been dominating national headlines for months, denoted as one of the worst public health crises in the US’s history, children born addicted to opiates are hardly discussed. If a woman uses prescription painkillers while their…
- Jason Edward Ochs
- August 16, 2018
Plastic surgeons are noticing more and more women contracting anaplastic large-cell lymphoma (ALCA), a rare type of cancer distinct from breast cancer, in those that have received breast enhancement surgeries. In 2011, the FDA noticed this trend but stated that…
- Jason Edward Ochs
- July 14, 2018
Johnson & Johnson (J&J) was ordered by a jury in the Circuit Court of the City of St. Louis to pay $4.14 billion in punitive damages and $550 million in compensatory damages to 22 women. The plaintiffs allege that their…
- Jason Edward Ochs
- June 12, 2018
Pharmaceutical giant AbbVie was threatened by the FDA in December, 2017 for not properly handling complaints that its drugs had been the cause of several deaths that had not been reported to the agency. The FDA had conducted an inspection…
- Jason Edward Ochs
- June 12, 2018
Producers of intragastric balloons, which are used in non-invasive weight loss procedures, are coming under investigation for a total of twelve deaths attributed to their use. These balloons are placed in one’s stomach through an…
- Jason Edward Ochs
- June 5, 2018
San Diego-based Acadia Pharmaceuticals released their first and only drug, Nuplazid, to the market in June of 2016. Coined a “breakthrough therapy” at the time, the medication sought to relieve Parkinson’s disease patients of hallucinations and psychosis. Nuplazid was approved…
- Jason Edward Ochs
- March 27, 2018
The Food and Drug Administration (FDA) distributed a warning letter to physicians concerning the risks of using Abbott Vascular’s Absorb GT1 Bioresorbable Vascular Scaffold (BVS) on March 18th, 2017. The BVS is a stent placed into one’s coronary artery…
- Jason Edward Ochs
- February 6, 2018
Recently reports have arisen linking the risk of vehicles with keyless ignition systems and carbon monoxide poisoning. Vehicles installed with the “on / off” button that automatically turns the vehicle on or off with a push of a button were…
